Cel
Within only six months, over 7.4 million people have been diagnosed with SARS-CoV-2. In the most severely hit countries, more than 10% of infected patients have received treatment in Intensive Care Units (ICUs). Insufficient data and limited knowledge on the disease as well as the lack of tools to support the intensivist in making accurate, timely and informed decisions has led to high mortality rates.
Continuous surveillance, the collection and intelligent analysis of data from many sources, including ventilators and electrical impedance tomography, would allow intensivists to decide on the best suitable treatment to accelerate the recovery of the often comorbid COVID-19 patients, while reducing the burden on clinical staff and healthcare costs. This information would also increase our understanding of the yet unknown course of disease, supporting other stakeholders in the quest for new therapies.
In ENVISION, our multidsciplinary public-private consortium will advance an innovative digital tool, Sandman.MD a real-time and plug-and-play monitoring app, to an intelligent decision-support system for monitoring, prediction and treatment of COVID-19 patients in ICUs – the Sandman.ICU – reaching Technology Readiness Level 9 and ready for CE marking by the end of the project. The app has been developed by our SME partner app@work and successfully introduced by several hospitals in Germany for use during the perioperative period. Sandman.ICU will be integrated into an AI-driven data analytics suite with predictive modelling tools and enhanced with a smart alert functionality. The digital tool will be validated and demonstrated in 14 hospitals across Europe. Our Health Technology Assessment expert partner will demonstrate the economic and societal value of Sandman.ICU while an experienced SME will manage the innovation process in view of an immediate market uptake. The rollout will be supported by the European Society of Anaesthesiology and Intensive Care.
Dziedzina nauki
Słowa kluczowe
Program(-y)
Zaproszenie do składania wniosków
H2020-SC1-PHE-CORONAVIRUS-2020-2
Zobacz inne projekty w ramach tego zaproszeniaSzczegółowe działanie
H2020-SC1-PHE-CORONAVIRUS-2020-2-CNECT
System finansowania
IA - Innovation actionKoordynator
60323 Frankfurt Am Main
Niemcy
Zobacz na mapie
Uczestnicy (22)
1085 Budapest
Zobacz na mapie
1097 Budapest
Zobacz na mapie
06123 Perugia
Zobacz na mapie
10124 Torino
Zobacz na mapie
50161 KAUNAS
Zobacz na mapie
3000-075 Coimbra
Zobacz na mapie
020021 Bucuresti
Zobacz na mapie
1000 Ljubljana
Zobacz na mapie
2000 Maribor
Zobacz na mapie
08007 Barcelona
Zobacz na mapie
Zakończenie uczestnictwa
WC1E 6BT London
Zobacz na mapie
8008 ZURICH
Zobacz na mapie
Organizacja określiła się jako MŚP (firma z sektora małych i średnich przedsiębiorstw) w czasie podpisania umowy o grant.
60327 Frankfurt Am Main
Zobacz na mapie
61449 Steinbach
Zobacz na mapie
33100 Tampere
Zobacz na mapie
9713 GZ Groningen
Zobacz na mapie
1000 Bruxelles / Brussel
Zobacz na mapie
69115 Heidelberg
Zobacz na mapie
300723 Timisoara
Zobacz na mapie
NW1 2PG London
Zobacz na mapie
93053 Regensburg
Zobacz na mapie
35037 MARBURG
Zobacz na mapie